CytomX Therapeutics (CTMX) P/E (2015 - 2026)
CytomX Therapeutics (CTMX) P/E from Dec 31, 2015 to Jul 21, 2026. The TTM CytomX Therapeutics (CTMX) P/E is 23.05. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of CytomX Therapeutics (CTMX)
| Year | P/E | Change |
|---|---|---|
| 2026 | 23.05 | -5.64% |
| 2025 | 24.43 | +364.12% |
| 2024 | 5.26 | -259.60% |
| 2023 | -3.30 | +368.50% |
| 2022 | -0.70 | -71.14% |
| 2021 | -2.44 | -74.06% |
| 2020 | -9.40 | -11.27% |
| 2019 | -10.60 | +38.88% |
| 2018 | -7.63 | -43.23% |
| 2017 | -13.44 | +90.54% |
| 2016 | -7.05 | -89.22% |
| 2015 | -65.45 | N/A |
Comparison CytomX Therapeutics (CTMX) P/E with competitors
CytomX Therapeutics (CTMX) P/E is 23.05.